Milk thistle, known for its silymarin content, is celebrated for protecting the liver against damage, reducing inflammation, ...

Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka), today announce positive topline interim data from the ongoing Phase 3 clinical trial of ...

RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flowThe ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

A study has shown that tuberculosis disrupts glucose metabolism in the liver, potentially leading to diseases like diabetes.

The London-based biotechnology company said the non-dilutive funding will support its ongoing development of its lead gene therapy, GF-1002, for the treatment of metabolic associated steatohepatitis, ...

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...

Polyploidy is a state where a cell contains more copies of the genetic material than the usual "diploid" cell, which contains ...

Diagnosing antibody-mediated rejection in liver transplant recipients is hindered by a lack of biomarkers and co-occurrence ...